Basilea Pharmaceutica AG
F:PK5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Basilea Pharmaceutica AG
F:PK5
|
CH |
|
F
|
Funding Circle Holdings PLC
F:FCA
|
UK |
|
CI Com SA
SIX:CIE
|
CH |
|
I
|
Integrated Wind Solutions ASA
OSE:IWS
|
NO |
|
D
|
DCC PLC
F:DCC
|
IE |
|
Enterex International Ltd
TWSE:1592
|
TW |
|
S
|
SCG Decor PCL
SET:SCGD
|
TH |
|
B90 Holdings PLC
F:24GN
|
IM |
|
I
|
Immuron Ltd
F:ANWA
|
AU |
|
Western Sierra Resource Corp
OTC:WSRC
|
US |
|
C
|
Cargosol Logistics Ltd
BSE:543621
|
IN |
|
F
|
FB Bancorp Inc
NASDAQ:FBLA
|
US |
|
Harbour Centre Development Ltd
HKEX:51
|
HK |
|
Pacific Premier Bancorp Inc
F:LF2
|
US |
|
K
|
KSH Holdings Ltd
SWB:XEUA
|
SG |
|
G
|
GEMXX Corp
OTC:GEMZ
|
US |
|
T
|
Three Valley Copper Corp
F:A7R
|
CA |
|
M
|
Move About Group AB
F:LW5
|
SE |
|
Lexinfintech Holdings Ltd
F:1LFA
|
CN |
|
P
|
P&S Mechanics Co Ltd
KOSDAQ:460940
|
KR |
|
ACNB Corp
NASDAQ:ACNB
|
US |
|
A
|
Anli International Co Ltd
TPEX:5223
|
TW |
|
Pradiksi Gunatama Tbk PT
IDX:PGUN
|
ID |
|
B
|
Baloise Holding AG
OTC:BLHEY
|
CH |
Wall St Price Targets
PK5 Price Targets Summary
Basilea Pharmaceutica AG
According to Wall Street analysts, the average 1-year price target for PK5 is 102.64 EUR with a low forecast of 72.35 EUR and a high forecast of 128.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PK5's stock price target?
Price Target
102.64
EUR
According to Wall Street analysts, the average 1-year price target for PK5 is 102.64 EUR with a low forecast of 72.35 EUR and a high forecast of 128.94 EUR.
What is the Revenue forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 2%.
What is the Gross Profit forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 2%.
What is the Operating Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
13%
The compound annual growth rate for Operating Income over the next 5 years is 13%.
What is the Pre-Tax Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
36%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 36%.
What is the Net Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
17%
The compound annual growth rate for Net Income over the next 5 years is 17%.
